Kestra Advisory Services, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Kestra Advisory Services, LLC
- $17.6 Billion
- Q2 2024
A detailed history of Kestra Advisory Services, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 15,500 shares of LXRX stock, worth $20,150. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,500
Previous 14,500
6.9%
Holding current value
$20,150
Previous $34,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LXRX
# of Institutions
131Shares Held
240MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4175MShares$228 Million18.64% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$12.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$10.8 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.68MShares$9.98 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.85MShares$7.6 Million0.24% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $245M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...